Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss may increase heart disease risk.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

Finasteride may cause kidney damage.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Autoimmune and metabolic issues are linked, and treating one may worsen another.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Anabolic-androgenic steroids are dangerous and educating people about their risks is essential.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

The document concludes that more research is needed to fully understand the causes of PCOS.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Pu-erh tea reduces hair loss risk in offspring.

Lichen planopilaris and frontal fibrosing alopecia are likely distinct diseases with different tissue involvement.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Vitamin D may help prevent or reduce hair loss after COVID-19.

Human skin can produce steroids from cholesterol.